Cart
sales@molnova.com
Licarbazepine
CAS No. 29331-92-8
Licarbazepine ( Licarbazepine;?1011-hydroxy-1011 Dihydrocarbamezer )
Catalog No. M21077 CAS No. 29331-92-8
Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 87 | Get Quote |
|
| 100MG | 110 | Get Quote |
|
| 200MG | 160 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLicarbazepine
-
NoteResearch use only not for human use.
-
Brief DescriptionLicarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
-
DescriptionLicarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
-
SynonymsLicarbazepine;?1011-hydroxy-1011 Dihydrocarbamezer
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationBipolar Disorder
Chemical Information
-
CAS Number29331-92-8
-
Formula Weight254.28
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:3mg/ml(11.7mM)
-
SMILESNC(=O)N1c2ccccc2CC(O)c2ccccc21
-
Chemical Name10-hydroxy-1011-dihydro-5H-dibenzo[bf]azepine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Begas E Tsakalof A Dardiotis E et al. Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment: HPLC method for licarbazepine monitoring in serum of patients[J]. Biomedical Chromatography 2017 31(9).
molnova catalog
related products
-
Menthyl isovalerate
Menthyl isovalerate is a bioactive chemical.
-
NPC 15199
NPC 15199 is an anti-inflammatory agent.NPC-15199 [(N-(9-fluorenylmethoxycarbonyl)L-leucine)], a novel anti-inflammatory agent, increases intracellular Ca2+ concentration ([Ca2+]i) in human bladder female transitional cancer (BFTC) cells.?
-
Visomitin
Visomitin (SKQ1 bromide, PDTP) is a mitochondria-targeted antioxidant that decreases transmembrane potential and production of reactive oxygen species (ROS).
